Schwannoma clinical trials at UC Cancer

2 research studies open to eligible people

Showing trials for

  • Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

    open to eligible people ages 12 years and up

    This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow people with multiple tumor types associated with NF2 to receive new drugs throughout this study. Embedded within the Master Study are individual drug substudies. - Investigational Drug Sub-study A: Brigatinib

    at UCLA

  • Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery

    open to eligible people ages 18-99

    This is a study of the feasibility of activating the auditory system by an electrode in direct contact with the cochlear nerve.

    at UC Irvine

Our lead scientists for Schwannoma medical studies include .

Last updated: